Completed OBSERVATIONAL NCT05483348

Clinical Predictive Factors of Success of Hysteroscopic Endometrial Ablation/Resection

Clinical Predictive Factors of Success of Hysteroscopic Endometrial Ablation/Resection; Retrospective Study at a Tertiary University Hospital

Sponsor: Naser Al-Husban

Conditions Prognostic Factors Treatment Failures Uterine Bleeding

Interventions Endometrial Ablation Repeated gynecological procedure

Updated 3 times since 2022 Last updated: Aug 1, 2022 Started: Feb 17, 2022 Primary completion: Apr 28, 2022 Completion: Apr 28, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05483348, this observational or N/A phase trial focuses on Prognostic Factors and Treatment Failures and remains completed. Sponsored by Naser Al-Husban, it has been updated 3 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Sep 2022 — Jul 2024 [monthly]

Completed

First recorded

Feb 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Naser Al-Husban

Data source: University of Jordan

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Amman, Jordan